<VariationArchive RecordType="classified" VariationID="14713" VariationName="NM_000208.4(INSR):c.2480_2487del (p.Gln827fs)" VariationType="Deletion" Accession="VCV000014713" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-24" DateCreated="2017-01-06" MostRecentSubmission="2017-01-06">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="29752" VariationID="14713">
      <GeneList>
        <Gene Symbol="INSR" FullName="insulin receptor" GeneID="3643" HGNC_ID="HGNC:6091" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="7112265" stop="7294414" display_start="7112265" display_stop="7294414" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="7112265" stop="7294010" display_start="7112265" display_stop="7294010" Strand="-" />
          </Location>
          <OMIM>147670</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000208.4(INSR):c.2480_2487del (p.Gln827fs)</Name>
      <CanonicalSPDI>NC_000019.10:7142870:GGTGTCCTGGT:GGT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="7142871" stop="7142878" display_start="7142871" display_stop="7142878" variantLength="8" positionVCF="7142870" referenceAlleleVCF="GGGTGTCCT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="7142882" stop="7142889" display_start="7142882" display_stop="7142889" variantLength="8" positionVCF="7142881" referenceAlleleVCF="GGGTGTCCT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>Q815fs</ProteinChange>
      <ProteinChange>Q827fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.7142874_7142881del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.7142874_7142881del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.7142885_7142892del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.7142885_7142892del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008852.2" sequenceAccession="NG_008852" sequenceVersion="2" change="g.156123_156130del">
            <Expression>NG_008852.2:g.156123_156130del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000208.4" sequenceAccession="NM_000208" sequenceVersion="4" change="c.2480_2487del" MANESelect="true">
            <Expression>NM_000208.4:c.2480_2487del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000199.2" sequenceAccession="NP_000199" sequenceVersion="2" change="p.Gln827fs">
            <Expression>NP_000199.2:p.Gln827fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001079817.3" sequenceAccession="NM_001079817" sequenceVersion="3" change="c.2444_2451del">
            <Expression>NM_001079817.3:c.2444_2451del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001073285.1" sequenceAccession="NP_001073285" sequenceVersion="1" change="p.Gln815fs">
            <Expression>NP_001073285.1:p.Gln815fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA124274" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="147670.0035" DB="OMIM" />
        <XRef Type="rs" ID="587776820" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000208.4(INSR):c.2480_2487del (p.Gln827fs) AND Rabson-Mendenhall syndrome" Accession="RCV000015828" Version="30">
        <ClassifiedConditionList TraitSetID="4062">
          <ClassifiedCondition DB="MedGen" ID="C0271695">Rabson-Mendenhall syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1998-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1998-02-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-01-06" MostRecentSubmission="2017-01-06">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27896077</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9449692</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="4062" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5764" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Mendenhall Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pineal Hyperplasia, Insulin-Resistant Diabetes Mellitus, and Somatic Abnormalities</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pineal hyperplasia AND diabetes mellitus syndrome</ElementValue>
                <XRef ID="Pineal+hyperplasia+AND+diabetes+mellitus+syndrome/9115" DB="Genetic Alliance" />
                <XRef ID="33559001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Rabson-Mendenhall syndrome</ElementValue>
                <XRef ID="MONDO:0009874" DB="MONDO" />
                <XRef ID="33559001" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="226" />
                <XRef ID="226" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">INSR-related severe syndromic insulin resistance comprises a phenotypic spectrum that is a continuum from the severe phenotype Donohue syndrome (DS) (also known as leprechaunism) to the milder phenotype Rabson-Mendenhall syndrome (RMS). DS at the severe end of the spectrum is characterized by severe insulin resistance (hyperinsulinemia with associated fasting hypoglycemia and postprandial hyperglycemia), severe prenatal growth restriction and postnatal growth failure, hypotonia and developmental delay, characteristic facies, and organomegaly involving heart, kidneys, liver, spleen, and ovaries. Death usually occurs before age one year. RMS at the milder end of the spectrum is characterized by severe insulin resistance that, although not as severe as that of DS, is nonetheless accompanied by fluctuations in blood glucose levels, diabetic ketoacidosis, and – in the second decade – microvascular complications. Findings can range from severe growth delay and intellectual disability to normal growth and development. Facial features can be milder than those of DS. Complications of longstanding hyperglycemia are the most common cause of death. While death usually occurs in the second decade, some affected individuals live longer.</Attribute>
                <XRef ID="NBK476444" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">INSR-Related Severe Syndromic Insulin Resistance</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29369573</ID>
                <ID Source="BookShelf">NBK476444</ID>
              </Citation>
              <XRef ID="769" DB="Orphanet" />
              <XRef ID="C0271695" DB="MedGen" />
              <XRef ID="MONDO:0009874" DB="MONDO" />
              <XRef Type="MIM" ID="262190" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="36095" SubmissionDate="2016-12-05" DateLastUpdated="2017-01-06" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="147670.0035_RABSON-MENDENHALL SYNDROME" title="INSR, 8-BP DEL, NT2480_RABSON-MENDENHALL SYNDROME" />
        <ClinVarAccession Accession="SCV000036095" DateUpdated="2017-01-06" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1998-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Ardon et al. (2014) cataloged this mutation as c.2480_2487del8 in exon 12 according to a revised INSR sequence (GenBank NC_000019).</Attribute>
              <Citation>
                <ID Source="PubMed">27896077</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">See 147670.0034 and Takahashi et al. (1998).</Attribute>
              <Citation>
                <ID Source="PubMed">9449692</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="INSR" />
          </GeneList>
          <Name>INSR, 8-BP DEL, NT2480</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">8-BP DEL, NT2480</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="147670.0035" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">RABSON-MENDENHALL SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="36095" TraitType="Disease" MappingType="Name" MappingValue="RABSON-MENDENHALL SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0271695" Name="Rabson-Mendenhall syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

